BR112014007025A2 - oligonucleotídeos, método in vitro de diagnóstico da tuberculose, kit diagnóstico e ácido nucleico - Google Patents
oligonucleotídeos, método in vitro de diagnóstico da tuberculose, kit diagnóstico e ácido nucleicoInfo
- Publication number
- BR112014007025A2 BR112014007025A2 BR112014007025A BR112014007025A BR112014007025A2 BR 112014007025 A2 BR112014007025 A2 BR 112014007025A2 BR 112014007025 A BR112014007025 A BR 112014007025A BR 112014007025 A BR112014007025 A BR 112014007025A BR 112014007025 A2 BR112014007025 A2 BR 112014007025A2
- Authority
- BR
- Brazil
- Prior art keywords
- oligonucleotides
- vitro
- nucleic acid
- diagnostic
- tuberculosis
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/5695—Mycobacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/115—Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/10—Applications; Uses in screening processes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/10—Detection of antigens from microorganism in sample from host
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Plant Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ZA201106987 | 2011-09-23 | ||
ZA201204226 | 2012-06-08 | ||
PCT/IB2012/055025 WO2013042077A1 (en) | 2011-09-23 | 2012-09-21 | Diagnosis of tuberculosis |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112014007025A2 true BR112014007025A2 (pt) | 2019-09-24 |
Family
ID=47146456
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112014007025A BR112014007025A2 (pt) | 2011-09-23 | 2012-09-21 | oligonucleotídeos, método in vitro de diagnóstico da tuberculose, kit diagnóstico e ácido nucleico |
Country Status (7)
Country | Link |
---|---|
US (2) | US9176134B2 (pt) |
EP (1) | EP2758062A1 (pt) |
AP (1) | AP3990A (pt) |
BR (1) | BR112014007025A2 (pt) |
RU (1) | RU2014115533A (pt) |
WO (1) | WO2013042077A1 (pt) |
ZA (1) | ZA201402437B (pt) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105358693A (zh) | 2013-03-18 | 2016-02-24 | 约翰内斯堡威特沃特斯兰德大学 | Cd7受体适配体 |
WO2014166558A1 (en) * | 2013-04-09 | 2014-10-16 | Tubitak (Turkiye Bilimsel Ve Teknolojik Arastirma Kurumu) | Dna aptamers to diagnose mycobacterium tuberculosis bacteria and treat tuberculosis disease, specific for m. tuberculosis bacteria |
CN106248934B (zh) * | 2016-08-25 | 2018-04-06 | 中国疾病预防控制中心传染病预防控制所 | 结核分枝杆菌抗原蛋白Rv0446c及其T细胞表位肽的应用 |
CN106248935B (zh) * | 2016-08-31 | 2018-04-06 | 中国疾病预防控制中心传染病预防控制所 | 结核分枝杆菌抗原蛋白Rv1798及其T细胞表位肽的应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7638271B2 (en) * | 2003-07-31 | 2009-12-29 | ICDDR, B: The Center for Health and Population Research | Use of antibody from lymphocyte secretions to diagnose active infection |
WO2008156471A1 (en) * | 2006-12-13 | 2008-12-24 | Stc.Unm | Non-invasive rapid diagnostic test for m. tuberculosis infection |
DE102007041476B4 (de) * | 2007-08-31 | 2017-03-30 | Rheinische Friedrich-Wilhelms-Universität Bonn | Aptamere, die an ein an der Hämostase beteiligtes Zielmolekül binden |
CN102549425A (zh) * | 2009-06-12 | 2012-07-04 | 疫苗技术公司 | 用于测量细胞介导的免疫应答的诊断试验所用的方法和组合物 |
-
2012
- 2012-09-21 WO PCT/IB2012/055025 patent/WO2013042077A1/en active Application Filing
- 2012-09-21 AP AP2014007565A patent/AP3990A/en active
- 2012-09-21 US US14/346,398 patent/US9176134B2/en not_active Expired - Fee Related
- 2012-09-21 RU RU2014115533/15A patent/RU2014115533A/ru unknown
- 2012-09-21 EP EP12783664.1A patent/EP2758062A1/en not_active Withdrawn
- 2012-09-21 BR BR112014007025A patent/BR112014007025A2/pt not_active IP Right Cessation
-
2014
- 2014-04-02 ZA ZA2014/02437A patent/ZA201402437B/en unknown
-
2015
- 2015-05-29 US US14/725,027 patent/US20150260716A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AP2014007565A0 (en) | 2014-04-30 |
EP2758062A1 (en) | 2014-07-30 |
AP3990A (en) | 2017-01-07 |
US20140370516A1 (en) | 2014-12-18 |
US20150260716A1 (en) | 2015-09-17 |
US9176134B2 (en) | 2015-11-03 |
ZA201402437B (en) | 2015-03-25 |
RU2014115533A (ru) | 2015-10-27 |
WO2013042077A1 (en) | 2013-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112014002621A2 (pt) | anticorpo, composição farmacêutica, combinação farmacêutica, dna e método de tratamento | |
HK1218573A1 (zh) | 用於純化核酸的方法和試劑盒 | |
EP3460064B8 (en) | Efficient protein expression in vivo using modified rna (mod-rna) | |
SG10201601638QA (en) | Nucleic acid detection method, and device and kit for use in same | |
EP2791159A4 (en) | MODIFIED NUCLEIC ACIDS, AND SHORT-TERM CARE USES THEREOF | |
DK3682905T3 (da) | Modificerede nukleosider, nukleotider og nukleinsyrer og anvendelser deraf | |
EP2702175A4 (en) | METHOD AND COMPOSITIONS FOR NUCLEIC ACID ANALYSIS | |
EP2788925A4 (en) | SYSTEM AND METHOD FOR EVALUATING AND MARKETING CLINICAL RESEARCH CENTERS | |
BR112013010725A2 (pt) | método, e, composição | |
GB201010557D0 (en) | RNA molecules and uses thereof | |
BR112013013584A2 (pt) | endoscópio, e, método | |
EP2631291A4 (en) | NUCLEIC ACID MOLECULES INDUCING RNA INTERFERENCE, AND USES THEREOF | |
GB201103726D0 (en) | Method, array and use thereof | |
BR112014022788A2 (pt) | peptídeo, polipeptídeos, ácido nucleico, composição farmacêutica, conjugado e método in vitro | |
GB201219137D0 (en) | Direct nucleic acid amplification kit, reagent and method | |
EP2691522A4 (en) | FUNCTIONAL NUCLEIC ACID MOLECULE AND APPLICATIONS THEREOF | |
EP2781536A4 (en) | BLOCK COPOLYMER IN WHICH A PHENYLBORONIC ACID GROUP HAS BEEN INTRODUCED, AND USE THEREOF | |
BR112013030381A2 (pt) | reagentes e métodos para tratar doença dental | |
BR112013012319A2 (pt) | inibidores de micro rna compreendendo nucleotídeos bloqueados | |
BR112013022766A2 (pt) | método de administração de d-pirfenidona e kit | |
EP2872036A4 (en) | IN VIVO BIOSENSOR | |
BR112013003528A2 (pt) | ''solução para extrair rna e métodos para extrair rna'' | |
GB201119903D0 (en) | Nucleic acid production and sequence analysis | |
EP2840389A4 (en) | BIOLOGICAL INFORMATION MEASURING DEVICE AND METHOD FOR MEASURING BIOLOGICAL INFORMATION USING THE SAME | |
BR112013022306A2 (pt) | método, e, composição |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application fees: dismissal - article 86 of industrial property law | ||
B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |